A randomized cross-over study was performed in 20 pediatric ALL patients ( age 1.9 - 14.6 years ) , comparing pharmacokinetics and pharmacodynamics of a newly developed 6MP liquid formulation to 6MP capsules , both taken orally for 4 weeks .